These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 10837472

  • 1. Mechanism of inhibition of the class A beta -lactamases PC1 and TEM-1 by tazobactam. Observation of reaction products by electrospray ionization mass spectrometry.
    Yang Y, Janota K, Tabei K, Huang N, Siegel MM, Lin YI, Rasmussen BA, Shlaes DM.
    J Biol Chem; 2000 Sep 01; 275(35):26674-82. PubMed ID: 10837472
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of TEM-2 beta-lactamase from Escherichia coli by clavulanic acid: observation of intermediates by electrospray ionization mass spectrometry.
    Brown RP, Aplin RT, Schofield CJ.
    Biochemistry; 1996 Sep 24; 35(38):12421-32. PubMed ID: 8823177
    [Abstract] [Full Text] [Related]

  • 3. Tazobactam inactivation of SHV-1 and the inhibitor-resistant Ser130 -->Gly SHV-1 beta-lactamase: insights into the mechanism of inhibition.
    Pagan-Rodriguez D, Zhou X, Simmons R, Bethel CR, Hujer AM, Helfand MS, Jin Z, Guo B, Anderson VE, Ng LM, Bonomo RA.
    J Biol Chem; 2004 May 07; 279(19):19494-501. PubMed ID: 14757767
    [Abstract] [Full Text] [Related]

  • 4. Inactivation of CMY-2 beta-lactamase by tazobactam: initial mass spectroscopic characterization.
    Bonomo RA, Liu J, Chen Y, Ng L, Hujer AM, Anderson VE.
    Biochim Biophys Acta; 2001 Jun 11; 1547(2):196-205. PubMed ID: 11410275
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of OXA-1 beta-lactamase by penems.
    Bethel CR, Distler AM, Ruszczycky MW, Carey MP, Carey PR, Hujer AM, Taracila M, Helfand MS, Thomson JM, Kalp M, Anderson VE, Leonard DA, Hujer KM, Abe T, Venkatesan AM, Mansour TS, Bonomo RA.
    Antimicrob Agents Chemother; 2008 Sep 11; 52(9):3135-43. PubMed ID: 18559643
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Kinetic interactions of tazobactam with beta-lactamases from all major structural classes.
    Bush K, Macalintal C, Rasmussen BA, Lee VJ, Yang Y.
    Antimicrob Agents Chemother; 1993 Apr 11; 37(4):851-8. PubMed ID: 8388201
    [Abstract] [Full Text] [Related]

  • 8. Why clinically used tazobactam and sulbactam are poor inhibitors of OXA-10 beta-lactamase: Raman crystallographic evidence.
    Totir MA, Cha J, Ishiwata A, Wang B, Sheri A, Anderson VE, Buynak J, Mobashery S, Carey PR.
    Biochemistry; 2008 Apr 01; 47(13):4094-101. PubMed ID: 18324783
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Characterization of a PSE-4 mutant with different properties in relation to penicillanic acid sulfones: importance of residues 216 to 218 in class A beta-lactamases.
    Sabbagh Y, Thériault E, Sanschagrin F, Voyer N, Palzkill T, Levesque RC.
    Antimicrob Agents Chemother; 1998 Sep 01; 42(9):2319-25. PubMed ID: 9736556
    [Abstract] [Full Text] [Related]

  • 11. Mechanism of inactivation of beta-lactamases by novel 6-methylidene penems elucidated using electrospray ionization mass spectrometry.
    Tabei K, Feng X, Venkatesan AM, Abe T, Hideki U, Mansour TS, Siegel MM.
    J Med Chem; 2004 Jul 01; 47(14):3674-88. PubMed ID: 15214794
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Tazobactam is a potent inactivator of selected inhibitor-resistant class A beta-lactamases.
    Bonomo RA, Rudin SA, Shlaes DM.
    FEMS Microbiol Lett; 1997 Mar 01; 148(1):59-62. PubMed ID: 9066111
    [Abstract] [Full Text] [Related]

  • 14. Comparative in-vitro activities of GD-40 and other beta-lactamase inhibitors against TEM-1 and SHV-2 beta-lactamases.
    Danelon G, Mascaretti O, Radice M, Power P, Calcagno ML, Mata EG, Gutkind G.
    J Antimicrob Chemother; 1998 Feb 01; 41(2):313-5. PubMed ID: 9533481
    [No Abstract] [Full Text] [Related]

  • 15. Identification of products of inhibition of GES-2 beta-lactamase by tazobactam by x-ray crystallography and spectrometry.
    Frase H, Smith CA, Toth M, Champion MM, Mobashery S, Vakulenko SB.
    J Biol Chem; 2011 Apr 22; 286(16):14396-409. PubMed ID: 21345789
    [Abstract] [Full Text] [Related]

  • 16. Rational design of a beta-lactamase inhibitor achieved via stabilization of the trans-enamine intermediate: 1.28 A crystal structure of wt SHV-1 complex with a penam sulfone.
    Padayatti PS, Sheri A, Totir MA, Helfand MS, Carey MP, Anderson VE, Carey PR, Bethel CR, Bonomo RA, Buynak JD, van den Akker F.
    J Am Chem Soc; 2006 Oct 11; 128(40):13235-42. PubMed ID: 17017804
    [Abstract] [Full Text] [Related]

  • 17. Interaction of tazobactam with Staphylococcus aureus PC1 beta-lactamase: a molecular modelling and enzyme kinetics study.
    Denny BJ, Toomer CA, Lambert PA.
    Microbios; 1994 Oct 11; 78(317):245-57. PubMed ID: 8078414
    [Abstract] [Full Text] [Related]

  • 18. Following the reactions of mechanism-based inhibitors with beta-lactamase by Raman crystallography.
    Helfand MS, Totir MA, Carey MP, Hujer AM, Bonomo RA, Carey PR.
    Biochemistry; 2003 Nov 25; 42(46):13386-92. PubMed ID: 14621983
    [Abstract] [Full Text] [Related]

  • 19. Cloning and sequencing of the gene encoding Toho-2, a class A beta-lactamase preferentially inhibited by tazobactam.
    Ma L, Ishii Y, Ishiguro M, Matsuzawa H, Yamaguchi K.
    Antimicrob Agents Chemother; 1998 May 25; 42(5):1181-6. PubMed ID: 9593147
    [Abstract] [Full Text] [Related]

  • 20. High resolution crystal structures of the trans-enamine intermediates formed by sulbactam and clavulanic acid and E166A SHV-1 {beta}-lactamase.
    Padayatti PS, Helfand MS, Totir MA, Carey MP, Carey PR, Bonomo RA, van den Akker F.
    J Biol Chem; 2005 Oct 14; 280(41):34900-7. PubMed ID: 16055923
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.